Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 4, 2025
Best Cutting and Bulking Steroids - Buy Oral Steroid Stacks for Muscle Gain, Fat Loss and Strength from CrazyBulk
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Using steroids for bodybuilding is typically divided into two distinct phases: the bulking phase and the cutting phase. Each phase has specific goals—bulking focuses on gaining muscle mass and strength, while …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …
Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation
GlobeNewswire
·
April 4, 2025
– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
RESEARCH TRIANGLE PARK, N.C., April 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees restricted stock units (RSUs) …
Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer’s Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting
GlobeNewswire
·
April 4, 2025
Late-breaking oral presentation of results from the positive pivotal ACCORD-2 Phase 3 trial of AXS-05 in Alzheimer’s disease agitation Presentation featuring network meta-analysis of SYMBRAVO® versus oral CGRPs NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- …
Verano to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 4, 2025
CHICAGO, April 04, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the first quarter ended …
New LabTAG Add-On Streamlines Laboratory Labeling with Dymo® LabelWriter™ 5-Series and eLabNext Integration
GlobeNewswire
·
April 4, 2025
BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its DYMO® LabelWriter™ 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab …